Cargando…

COVID-19 vaccine hesitancy in patients with mental illness: strategies to overcome barriers—a review

BACKGROUND: People with mental health problems are at particular risk both for infection with COVID-19 and for more severe course of illness. Understanding COVID-19 vaccine hesitancy is crucial in promoting vaccine acceptance among people with mental health diagnoses. This review aims to identify th...

Descripción completa

Detalles Bibliográficos
Autores principales: Payberah, Ebrahim, Payberah, Daniel, Sarangi, Ashish, Gude, Jayasudha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777419/
https://www.ncbi.nlm.nih.gov/pubmed/35079435
http://dx.doi.org/10.1186/s42506-022-00102-8
_version_ 1784637066170073088
author Payberah, Ebrahim
Payberah, Daniel
Sarangi, Ashish
Gude, Jayasudha
author_facet Payberah, Ebrahim
Payberah, Daniel
Sarangi, Ashish
Gude, Jayasudha
author_sort Payberah, Ebrahim
collection PubMed
description BACKGROUND: People with mental health problems are at particular risk both for infection with COVID-19 and for more severe course of illness. Understanding COVID-19 vaccine hesitancy is crucial in promoting vaccine acceptance among people with mental health diagnoses. This review aims to identify the prevalence and discuss factors associated with COVID-19 vaccine hesitancy among the mentally ill population. MAIN BODY: We conducted a detailed literature search and included 15 articles for discussion in this review. Several studies showed varying trends of vaccine hesitancy rates among different countries. Major factors involved in vaccine hesitancy in general include mistrust, misinformation, believing in conspiracy theories, and negative attitudes towards vaccines. It was surprising that none of the studies were focused on vaccine acceptance rates and factors associated with vaccine hesitancy among the mentally ill population. However, studies do show that COVID-19 is associated with worse healthcare outcomes for psychiatric patients, and vaccine hesitancy correlated with a lower likelihood of receiving mental health treatment and vaccinations. Psychiatrists need to address issues among patients who are particularly vulnerable to the fear of vaccines which include anxiety, panic attacks, certain phobias including trypanophobia and agoraphobia, obsessive-compulsive disorder, and certain types of traumas. Psychiatrists need to communicate effectively, show respect, empathy, and deliver accurate and honest information about the vaccines. Motivational interviewing, getting people with mental health illness to organize vaccine campaigns, and involving families with mental health problems may promote vaccine acceptance among this group. CONCLUSION: Existing literature on the rates of vaccine hesitancy among people with mental health illness is limited. The mental health illness may increase the risk of hesitancy especially in patients having certain emotional disorders such as anxiety and phobia. More studies addressing vaccine hesitancy rates and factors associated with the mentally ill population need to be done in the future.
format Online
Article
Text
id pubmed-8777419
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-87774192022-01-21 COVID-19 vaccine hesitancy in patients with mental illness: strategies to overcome barriers—a review Payberah, Ebrahim Payberah, Daniel Sarangi, Ashish Gude, Jayasudha J Egypt Public Health Assoc Review BACKGROUND: People with mental health problems are at particular risk both for infection with COVID-19 and for more severe course of illness. Understanding COVID-19 vaccine hesitancy is crucial in promoting vaccine acceptance among people with mental health diagnoses. This review aims to identify the prevalence and discuss factors associated with COVID-19 vaccine hesitancy among the mentally ill population. MAIN BODY: We conducted a detailed literature search and included 15 articles for discussion in this review. Several studies showed varying trends of vaccine hesitancy rates among different countries. Major factors involved in vaccine hesitancy in general include mistrust, misinformation, believing in conspiracy theories, and negative attitudes towards vaccines. It was surprising that none of the studies were focused on vaccine acceptance rates and factors associated with vaccine hesitancy among the mentally ill population. However, studies do show that COVID-19 is associated with worse healthcare outcomes for psychiatric patients, and vaccine hesitancy correlated with a lower likelihood of receiving mental health treatment and vaccinations. Psychiatrists need to address issues among patients who are particularly vulnerable to the fear of vaccines which include anxiety, panic attacks, certain phobias including trypanophobia and agoraphobia, obsessive-compulsive disorder, and certain types of traumas. Psychiatrists need to communicate effectively, show respect, empathy, and deliver accurate and honest information about the vaccines. Motivational interviewing, getting people with mental health illness to organize vaccine campaigns, and involving families with mental health problems may promote vaccine acceptance among this group. CONCLUSION: Existing literature on the rates of vaccine hesitancy among people with mental health illness is limited. The mental health illness may increase the risk of hesitancy especially in patients having certain emotional disorders such as anxiety and phobia. More studies addressing vaccine hesitancy rates and factors associated with the mentally ill population need to be done in the future. Springer Berlin Heidelberg 2022-01-21 /pmc/articles/PMC8777419/ /pubmed/35079435 http://dx.doi.org/10.1186/s42506-022-00102-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Payberah, Ebrahim
Payberah, Daniel
Sarangi, Ashish
Gude, Jayasudha
COVID-19 vaccine hesitancy in patients with mental illness: strategies to overcome barriers—a review
title COVID-19 vaccine hesitancy in patients with mental illness: strategies to overcome barriers—a review
title_full COVID-19 vaccine hesitancy in patients with mental illness: strategies to overcome barriers—a review
title_fullStr COVID-19 vaccine hesitancy in patients with mental illness: strategies to overcome barriers—a review
title_full_unstemmed COVID-19 vaccine hesitancy in patients with mental illness: strategies to overcome barriers—a review
title_short COVID-19 vaccine hesitancy in patients with mental illness: strategies to overcome barriers—a review
title_sort covid-19 vaccine hesitancy in patients with mental illness: strategies to overcome barriers—a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777419/
https://www.ncbi.nlm.nih.gov/pubmed/35079435
http://dx.doi.org/10.1186/s42506-022-00102-8
work_keys_str_mv AT payberahebrahim covid19vaccinehesitancyinpatientswithmentalillnessstrategiestoovercomebarriersareview
AT payberahdaniel covid19vaccinehesitancyinpatientswithmentalillnessstrategiestoovercomebarriersareview
AT sarangiashish covid19vaccinehesitancyinpatientswithmentalillnessstrategiestoovercomebarriersareview
AT gudejayasudha covid19vaccinehesitancyinpatientswithmentalillnessstrategiestoovercomebarriersareview